Huron Consulting Group Inc. (NASDAQ: HURN), a leading provider of business consulting services, today announced that the Company recently completed its acquisition of The Frankel Group Associates LLC, a leading life sciences consulting firm. The acquisition expands Huron’s strategy, operations, advanced analytics, and regulatory compliance offerings to life sciences companies and to the law firms and investment firms that serve these companies. Frankel Group’s diverse client base includes global pharmaceutical, emerging bio/pharmaceutical, medical device and diagnostic companies as well as the law firms and investment firms serving the life sciences industry. “We are thrilled to have the Frankel and Huron Life Sciences teams joined together to serve the critical needs of our clients,” said Paul Silver, managing director and leader for Huron Life Sciences. “Approximately 50 Frankel Group professionals are now part of the Huron Life Sciences team. Along with founder Barry Frankel, the following individuals have been named managing directors at Huron: Lester Cheng, Nathan Dowden, David Gilman, Benjamin Rymzo, and Marc Tomassi.” Terms of the transaction were not disclosed. For reporting purposes, Frankel Group will be included in the Huron Education and Life Sciences segment. About Huron Life Sciences Huron Life Sciences serves pharmaceutical, medical device and biotechnology companies, healthcare providers, academic medical centers and the law firms and investment firms that support these organizations to achieve financial, operational, and strategic objectives. Learn more at www.huronconsultinggroup.com/lifesciences or follow us on Twitter: @Huron. About Huron Consulting Group Huron Consulting Group helps clients in diverse industries improve performance, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth. Our professionals employ their expertise in administration, management, finance, operations, strategy, business intelligence and technology to provide our clients with specialized analyses and customized advice and solutions that are tailored to address each client's particular challenges and opportunities to deliver sustainable and measurable results. The Company provides consulting services to a wide variety of both financially sound and distressed organizations, including healthcare organizations, leading academic institutions, Fortune 500 companies, governmental entities and law firms. Huron has worked with more than 90 of the top 100 research universities, more than 400 corporate general counsel, and more than 385 hospitals and academic medical centers. Learn more at www.huronconsultinggroup.com. Statements in this press release that are not historical in nature, including those concerning the Company’s current expectations about its future requirements and needs, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans” or “continues.” These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements, including, without limitation, current expectations with respect to, among other factors, utilization rates, billing rates, and the number of revenue-generating professionals; that we are able to expand our service offerings; that we successfully integrate the businesses we acquire; and that existing market conditions continue to trend upward. These statements involve known and unknown risks, uncertainties and other factors, including, among others, those described under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2012 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.